Synonym:
6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid,
6-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid,
Adapalene,
CD-271,
Differin
Properties:
Related Categories |
Additional Standards,
Analytical Standards,
Analytical/Chromatography,
Chromatography,
Pharmaceutical Secondary Standards,
|
grade
|
certified reference material
|
|
pharmaceutical secondary standard
|
InChI Key
|
LZCDAPDGXCYOEH-AADAIPAGSA-N
|
form
|
neat
|
format
|
neat
|
pharmacopeia traceability
|
traceable to PhEur Y0001121
|
|
traceable to USP 1011709
|
Description:
Analysis Note
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
General description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Other Notes
This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).
Biochem/physiol Actions
Retinoic acid analogue that is a RARβ and RARγ agonist (AC50 values are 2.2, 9.3, 22 and > 1000 nM for RARβ, RARγ, RARα and RXRα receptors respectively). Inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro. Displays comedolytic activity. Its unique pharmacological properties make it superior to other retinoids for the treatment of acne.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAA1895 in the slot below. This is an example certificate only and may not be the lot that you receive.
Safety:
RIDADR
NONH for all modes of transport